Compare LMB & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMB | SDGR |
|---|---|---|
| Founded | 1901 | 1990 |
| Country | United States | United States |
| Employees | 1400 | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 960.5M | 925.8M |
| IPO Year | 2014 | 2020 |
| Metric | LMB | SDGR |
|---|---|---|
| Price | $79.56 | $14.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $116.67 | $21.00 |
| AVG Volume (30 Days) | 323.5K | ★ 1.3M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.68 | ★ 45.14 |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $646,804,000.00 | $255,869,000.00 |
| Revenue This Year | $15.96 | $0.76 |
| Revenue Next Year | $5.90 | $4.60 |
| P/E Ratio | $234.25 | ★ N/A |
| Revenue Growth | ★ 24.68 | 23.29 |
| 52 Week Low | $65.08 | $10.95 |
| 52 Week High | $154.04 | $27.63 |
| Indicator | LMB | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 49.10 | 55.62 |
| Support Level | $76.97 | $11.27 |
| Resistance Level | $85.38 | $19.51 |
| Average True Range (ATR) | 4.91 | 0.90 |
| MACD | 1.16 | 0.17 |
| Stochastic Oscillator | 63.27 | 53.39 |
Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.